Clinical DevelopmentRisks include clinical development, competition, novel modality, commercialization, reimbursement, pricing, business development, and clinical trial risks due to the war in Eastern Europe.
Market CompetitionCompetitive PV landscape with five key assets at different stages of development implies a challenging market entry.
Safety/TolerabilityPV treatments for high-risk patients carry safety/tolerability risks, which may limit their use.